The agency gave an emergency use authorization to the testing assay, developed by Rutgers University, Spectrum Solutions and Accurate Diagnostic Labs, for collection of samples at home. The saliva-based test was originally authorized last month.
The test, designed at Rutgers University under a partnership with Spectrum Solutions and Accurate Diagnostic Labs, is designed to allow for broader population screening than the current, more prevalent method of nose and throat swabs.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.